Introduction

Polio used to be common in the United States. Before the polio vaccine, the disease killed thousands of people every year. Thanks to the polio vaccine, there has not been a new case of polio in the United States in over 40 years.

What is polio?

Polio is caused by a virus. Most people who get polio do not have any symptoms. When people do get symptoms, they may include:

• Sore throat
• Fever
• Upset stomach
• Headache
• Stomach pain

Sometimes polio can affect the brain, and lead to serious - and permanent - complications like:

• Paresthesia (feeling pins and needles)
• Inflammation of the lining of the brain and spinal cord
• Paralysis (not being able to move)
• Polio usually spreads when someone gets certain body fluids or poop from a person with polio on their hands and then touches their own mouth.

Polio spreads when:

• Someone who has polio coughs or sneezes
• Someone who has polio does not wash their hands properly after going to the bathroom and then touches food or objects

Importance of vaccine

Polio is a very contagious disease - it spreads easily from person to person. Most people who get polio do not have any serious problems. But in some cases, polio can be very dangerous and lead to permanent disabilities - and even death.

Even though it is rare in the United States, polio still exists in a few countries in Asia and Africa. So, it is possible for people to get polio when they travel - and spread it to people who are not vaccinated when they come home.

Who need polio vaccine?

Children need doses at the following ages:

• 2 months for the first dose
• 4 months for the second dose
• 6 through 18 months for the third dose
• 4 through 6 years for the fourth dose

Adults

Some adults who are at higher risk of getting polio may need 1 to 3 doses of the polio vaccine, depending on whether they have been vaccinated in the past

Side effects

Side effects are usually mild and go away in a few days. The most common side effect people have is a sore spot where they got the shot.

Conclusion

Our Journal is planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles within the short time.

 A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.

Manuscripts can be forwarded to the Editorial Office at autoimmunedis@eclinicalsci.com

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Media Contact:
John Kimberly
Editorial Manager
Journal of Vaccines & Vaccination
Email: jvv@scholarlypub.com